The goal of the clinical trial is to compare laser therapy with ultrasonic therapy in patients with inflammation in the tissue surrounding single implants (peri-implant mucositis). The outcomes are bleeding on probing (BOP), pocket depth, suppuration, recession of the peri-implant mucosal margin, the treatment time and changes in bone levels before and after treatment in the test, and control group respectively. The quality of life will be measured from a standardized protocol. The hypothesis is that treatment with laser therapy in patients with peri-implant mucositis will show less inflammation with less bleeding and a better pocket closure compared to the treatment with the ultrasound.
Age range
23 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Bleeding on probing (BOP)
Timeframe: Baseline
Bleeding on probing (BOP)
Timeframe: 1 month
Bleeding on probing (BOP)
Timeframe: 3 months
Bleeding on probing (BOP)
Timeframe: 6 months
Probing pocket depth (PPD)
Timeframe: Baseline
Probing pocket depth (PPD)
Timeframe: 1 month
Probing pocket depth (PPD)
Timeframe: 3 months
Probing pocket depth (PPD)
Timeframe: 6 months
Pus
Timeframe: Baseline
Pus
Timeframe: 1 month
Pus
Timeframe: 3 months
Pus
Timeframe: 6 months